PEN 17 - A Hard Pill to Swallow

Barriers to Effective FDA Regulation of Nanotechnology-Based Dietary Supplements

William B. Schultz and Lisa Barclay

View

WASHINGTON - Historically, the regulation of dietary supplements has been a significant challenge for the U.S. Food and Drug Administration (FDA), and the fact that some of these products are now being manufactured using nanotechnology creates an additional layer of complexity.

This new report asks the question: Is FDA equipped to meet the emerging regulatory challenge of dietary supplements that use engineered nanomaterials? The short answer is no.

Related:

• Event Release Page/Webcast

• Press release about report

• Consumer Products Inventory